The peptide therapeutics contract manufacturing market was valued at USD 3.38 billion in 2025 and is estimated at USD 3.91 billion in 2026. It is projected to reach USD 10.79 billion by 2035, representing a CAGR of 11.94% during 2026-2035. Growth is being supported by the expanding commercial pipeline for peptide therapeutics and greater reliance on specialized external manufacturing capacity.

The global acute ischemic stroke therapeutics market, valued at USD 1,920 million in 2025, is projected to reach USD 2,077 million in 2026 and USD 3,917 million by 2035, representing a CAGR of 7.3% during the forecast period from 2026 to 2035. In terms of the type of molecule, biologics hold the highest share (nearly 55%) of the current market. By drug class, thrombolytics dominate the current acute ischemic stroke therapeutics market.

The global veterinary vaccines market, valued at USD 12.8 billion in 2025, is projected to reach USD 13.4 billion in 2026 and USD 22.0 billion by 2035, representing a CAGR of 5.69% during the forecast period 2026 to 2035. Around 60% of the known infectious diseases are zoonotic in origin (transmitted from animals to humans), responsible for 2.5 billion disease cases and 2.7 million human deaths every year, across the globe. Vaccination of animals helps protect animals as well as human population...

The North America AI in clinical trials market, valued at USD 0.80 billion in 2025, is projected to reach USD 0.91 billion in 2026 and USD 2.58 billion by 2035, with a CAGR of 12.4% during the forecast period, 2026 to 2035. Based on the deployment mode, cloud-based AI solutions capture the largest share of the current market, and the trend is unlikely to change in the future.

The Europe AI in clinical trials market, valued at USD 0.90 billion in 2025, is projected to reach USD 1.01 billion in 2026 and USD 2.76 billion by 2035, with a CAGR of 11.8% during the forecast period, 2026 to 2035. In June 2026, Owkin entered a multiyear collaboration with Sanofi to build K Pro biopharma AI agents backed by a five-year K Pro license. K Pro uses multimodal patient data and agentic AI to support decisions from early discovery through clinical development. In April 2026, Boehring...

The global pharmaceutical knowledge graph market reached USD 0.58 billion in 2026 and is projected to reach USD 5.00 billion by 2040, growing at a CAGR of 16.6% over the forecast period 2026 to 2040, driven by growing demand for explainable AI and connected biomedical evidence Based on offering, knowledge graph platforms capture 34.0% market share in 2026, whereas semantic enrichment and ontology-management tools register a 17.8% CAGR through 2040, supported by growing demand for governed biomed...

The GLP-1 receptor agonist market size, valued at USD 78 billion in 2025, is projected to reach USD 101.4 billion in 2026 and USD 180 billion by 2035, representing a CAGR of 6.6% during the forecast period 2026 to 2035. Growth is concentrated in three visible shifts: oral small-molecule formulations are gaining share against long-established injectable therapies, expanding patient populations beyond type 2 diabetes into obesity and adjacent metabolic conditions are pulling in new prescriber and...

The global pharmaceutical contract manufacturing market size, valued at USD 100.3 billion in 2025, is projected to reach USD 104.4 billion in 2026 and USD 155.4 billion by 2035, with a CAGR of 4.5% during the forecast period 2026 to 2035. This market is growing steadily, driven by the increased extent of outsourcing, thereby accelerating the time-to-market. In terms of API potency, low potent API sub-segment currently holds around 85% of the market share, due to their widespread application, low...

The global aseptic fill finish manufacturing market, valued at USD 7.5 billion in 2025, is projected to reach USD 8.1 billion in 2026 and USD 13.3 billion by 2035, with a CAGR of 5.7% during the forecast period 2026 to 2035. This market is growing steadily, driven by the increased awareness related to the benefits of aseptic fill finish services across biologics and small molecules. Amongst biologics, antibodies capture the largest (60%) share of the market; this trend is unlikely to change in t...

The global radiopharmaceutical logistics market, valued at USD 0.99 billion in 2025, is projected to reach USD 1.10 billion in 2026 and USD 3.13 billion by 2035, representing a CAGR of 12.31% during the forecast period 2026 to 2035. Market growth is expected to be supported by the expanding commercialization of diagnostic and therapeutic radiopharmaceuticals, increasing nuclear-medicine and treatment-site capacity, greater reliance on specialist outsourced logistics providers, and rising require...

The global medical isotope production market, valued at USD 6.7 billion in 2025, is projected to reach USD 7.5 billion in 2026 and USD 18.0 billion by 2040, representing a CAGR of 6.4% during the forecast period 2026 to 2040. Advanced therapeutics such as Lutetium-177, Thorium-228, and Yttrium-90 are involved in targeted radionuclide therapies. Diagnostic isotopes such as fluorine-18 and technetium-99m are widely used in PET and SPECT imaging, respectively. Technetium-99m is commonly obtained fr...

The global computational pathology market is expected to rise from USD 0.78 billion in 2026 to reach USD 2.46 billion by 2040, growing at a CAGR of 8.6% over the forecast period 2026 to 2040, driven by AI-enabled precision diagnostics and scalable digital workflows. Based on therapeutic area, oncology is both the dominant and fastest-growing category, holding 54.0% share in 2026 and expanding at 9.1% CAGR through 2040, driven by companion-diagnostic adoption. Based on end user, hospitals capture...

The global single-use bioprocessing consumables market, valued at USD 8.1 billion in 2025, is projected to reach USD 8.9 billion in 2026 and USD 21.4 billion by 2035, representing a CAGR of 10.2% during the forecast period from 2026 to 2035. Recent capacity expansions demonstrate the growing commercial importance of the category. In June 2025, Sartorius expanded its Aubagne facility in France, nearly doubling its cleanroom space to approximately 9,000 m² and increasing capacity for single-use b...

The global single-use chromatography systems market, valued at USD 1.8 billion in 2025, is projected to reach USD 2.0 billion in 2026 and USD 6.3 billion by 2035, representing a CAGR of 13.7% during the forecast period from 2026 to 2035. The growing scale of biologics manufacturing is increasing demand for advanced downstream purification infrastructure. In 2026, Aurobindo Pharma’s subsidiary TheraNym announced plans to invest USD 150–175 million in a new biologic drug substance facility for...

The global Injectable PrEP Market is expected to rise from USD 1.62 billion in 2026 and is projected to reach USD 7.15 billion by 2040, growing at a CAGR of 11.2% over the forecast period 2026 to 2040, driven by six-month dosing, reimbursement expansion, and generic access. Based on care setting, hospitals and specialist clinics capture 74.0% market share in 2026, whereas retail and community pharmacies register a 23.8% CAGR through 2040, supported by decentralized delivery. Based on funding and...

The global plasmid DNA manufacturing market, valued at USD 317 million in 2025, is projected to reach USD 395 million in 2026 and USD 2,689 million by 2035, representing a CAGR of 23.74% during the forecast period 2026 to 2035. The success of plasmid-based platforms during the COVID-19 pandemic (used by companies like Moderna and Pfizer-BioNTech) highlighted their importance in rapid vaccine development. This has driven sustained demand for plasmid DNA in DNA / RNA vaccines, infectious disease r...

The Asia-Pacific AI in clinical trials market, valued at USD 1.40 billion in 2025, is projected to reach USD 1.61 billion in 2026 and USD 5.07 billion by 2035, with a CAGR of 13.6% during the forecast period, from 2026 to 2035. For instance, in March 2025, AstraZeneca invested USD 2.5 billion in a new strategic R&D center in Beijing, supported by an AI and data science laboratory, designed to advance early-stage research and clinical development. In June 2026, HistoIndex and D&D Pharmatech annou...

The global radiopharmaceuticals market, valued at USD 11.5 billion in 2025, is projected to reach USD 13.1 billion in 2026 and USD 38.6 billion by 2040, representing a CAGR of 8.0% during the forecast period 2026 to 2040. Amongst the type of radioisotope, Technetium-99m captures the most (close to 50%) of the current market.

The global nanobody therapeutics market reached USD 0.60 billion in 2026 and is projected to reach USD 6.60 billion by 2040, growing at a CAGR of 18.7% over the forecast period 2026 to 2040, driven by multi-specific pipeline expansion and localized delivery. Compact single-domain formats are shifting the nanobody therapeutics market from one-product validation toward diversified clinical and discovery pipelines. Earlier revenues depended heavily on bivalent hematology products and camelid-derive...

The global vaginal microbiome testing market is expected to rise from USD 175 million in 2026 to reach USD 572.0 million by 2040, growing at a CAGR of 8.8% over the forecast period 2026 to 2040, driven by molecular diagnostics and convenient self-collection. Based on offering type, laboratory testing services capture 44.0% market share in 2026, whereas data analysis and interpretation platforms register an 11.1% CAGR through 2040, supported by expanding test volumes and automated clinical interp...